Page last updated: 2024-08-24

toltrazuril and Adverse Drug Event

toltrazuril has been researched along with Adverse Drug Event in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freudenschuss, B; Hinney, B; Joachim, A; Karembe, H; Palmieri, N; Shrestha, A; Sperling, D1
Altreuther, G; Kok, DJ; Petry, G; Swart, P; Wolken, S1

Trials

2 trial(s) available for toltrazuril and Adverse Drug Event

ArticleYear
Comparison of an injectable toltrazuril-gleptoferron (Forceris®) and an oral toltrazuril (Baycox®) + injectable iron dextran for the control of experimentally induced piglet cystoisosporosis.
    Parasites & vectors, 2018, 03-27, Volume: 11, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Animals; Animals, Newborn; Body Weight; Coccidiosis; Coccidiostats; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Iron-Dextran Complex; Sarcocystidae; Swine; Swine Diseases; Treatment Outcome; Triazines

2018
Efficacy of emodepside plus toltrazuril oral suspension for dogs (Procox®, Bayer) against Trichuris vulpis in naturally infected dogs.
    Parasitology research, 2013, Volume: 112 Suppl 1

    Topics: Administration, Oral; Ancylostomatoidea; Animals; Anthelmintics; Coinfection; Depsipeptides; Dogs; Double-Blind Method; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Feces; Parasite Load; Suspensions; Treatment Outcome; Triazines; Trichuriasis; Trichuris

2013